Our bodies are one big metabolic reaction producing a plethora of volatile organic compounds (VOCs) which are the basis for our proprietary composite biomarker. These VOCs are released into the blood and can be detected in our breath. Like dogs and people can smell disease, our technology measures VOCs, the underlying signature of disease.
VOCs in our breath can tell a story about what may be going wrong inside of our bodies. Breathe BioMedical’s technology is being developed to detect biomarkers of cancer, neurologic, cardiac, and respiratory diseases, often long before symptoms appear.
Our platform combines three advanced technologies to sample, digitize and analyze biomarkers to screen for disease.